← Eichor
Study identifier: NCT07229040 Synced from ClinicalTrials.gov · July 27, 2026
● Recruiting

A Double-blind Non Inferiority Clinical Trial to Compare the Nephroprotection of Cilastatn Versus Thiosulfate in Patients Undergoing Debulking Surgery With Intraoperative Hyperthermic Intraperitoneal Chemotherapy With Cisplatin.

Condition: Debulking Surgery for Ovarian Cancer · Acute Kidney Injury  ·  Sponsor: Hospital General Universitario Gregorio Marañon

PhasePhase 2
Planned participants90
Who can joinFemale, 18 Years to 75 Years
Healthy volunteersNo

About this study

To compare cilastatin vs thiosulfatein renal protection in patients undergoing debulking surgery with intraoperative hyperthermic intraperitoneal chemotherapy with cisplatin

This description comes directly from the study's public registry record.

Talk to the study team

Alberto Lazaro, PhD  ·  +34914265115  ·  alazaro10@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hodpsital General Universitario Gregorio MarañónMadrid, Madrid, SpainRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07229040